Norris Financial Group’s ImmunityBio IBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$108K	Hold	14,126	–	–	0.04%	97
2025 Q4	$28K	Hold	14,126	–	–	0.01%	97
2025 Q3	$34.8K	Hold	14,126	–	–	0.01%	98
2025 Q2	$37.3K	Hold	14,126	–	–	0.02%	82
2025 Q1	$42.5K	Hold	14,126	–	–	0.02%	85
2024 Q4	$36.2K	Hold	14,126	–	–	0.02%	81
2024 Q3	$52.5K	Buy	14,126 +376	+3%	+$1.74K	0.03%	75
2024 Q2	$86.9K	Buy	13,750 +2,750	+25%	+$18.1K	0.05%	77
2024 Q1	$59.1K	Hold	11,000	–	–	0.03%	74
2023 Q4	$55.2K	Hold	11,000	–	–	0.03%	67
2023 Q3	$18.6K	Hold	11,000	–	–	0.01%	63
2023 Q2	$30.6K	Sell	11,000 -1,000	-8%	-$2.83K	0.02%	63
2023 Q1	$21.8K	Buy	+12,000	New	+$37.3K	0.02%	65